185 related articles for article (PubMed ID: 19760557)
61. Novel therapy for Hodgkin lymphoma.
Batlevi CL; Younes A
Hematology Am Soc Hematol Educ Program; 2013; 2013():394-9. PubMed ID: 24319210
[TBL] [Abstract][Full Text] [Related]
62. Flow-sorting and Exome Sequencing of the Reed-Sternberg Cells of Classical Hodgkin Lymphoma.
Reichel JB; McCormick J; Fromm JR; Elemento O; Cesarman E; Roshal M
J Vis Exp; 2017 Jun; (124):. PubMed ID: 28654052
[TBL] [Abstract][Full Text] [Related]
63. Hodgkin lymphoma: clinical, morphologic, immunophenotypic, and molecular characteristics.
Schnitzer B; Valdez R
Cancer Treat Res; 2004; 121():259-90. PubMed ID: 15217214
[No Abstract] [Full Text] [Related]
64. HIV-associated Hodgkin lymphoma.
Carbone A; Gloghini A; Serraino D; Spina M
Curr Opin HIV AIDS; 2009 Jan; 4(1):3-10. PubMed ID: 19339934
[TBL] [Abstract][Full Text] [Related]
65. World Health Organization and beyond: new aspects in the pathology of an old disease.
Hummel M
Hematol Oncol Clin North Am; 2007 Oct; 21(5):769-86. PubMed ID: 17908619
[TBL] [Abstract][Full Text] [Related]
66. Expression of Grb2 distinguishes classical Hodgkin lymphomas from primary mediastinal B-cell lymphomas and other diffuse large B-cell lymphomas.
Miles RR; Mankey CC; Seiler CE; Smith LB; Teruya-Feldstein J; Hsi ED; Elenitoba-Johnson KS; Lim MS
Hum Pathol; 2009 Dec; 40(12):1731-7. PubMed ID: 19716163
[TBL] [Abstract][Full Text] [Related]
67. IL-21 is expressed in Hodgkin lymphoma and activates STAT5: evidence that activated STAT5 is required for Hodgkin lymphomagenesis.
Scheeren FA; Diehl SA; Smit LA; Beaumont T; Naspetti M; Bende RJ; Blom B; Karube K; Ohshima K; van Noesel CJ; Spits H
Blood; 2008 May; 111(9):4706-15. PubMed ID: 18296629
[TBL] [Abstract][Full Text] [Related]
68. Proteomics analysis of Hodgkin lymphoma: identification of new players involved in the cross-talk between HRS cells and infiltrating lymphocytes.
Ma Y; Visser L; Roelofsen H; de Vries M; Diepstra A; van Imhoff G; van der Wal T; Luinge M; Alvarez-Llamas G; Vos H; Poppema S; Vonk R; van den Berg A
Blood; 2008 Feb; 111(4):2339-46. PubMed ID: 18070985
[TBL] [Abstract][Full Text] [Related]
69. JAK/STAT blockade reverses the malignant phenotype of Hodgkin and Reed-Sternberg cells.
Fernández S; Solórzano JL; Díaz E; Menéndez V; Maestre L; Palacios S; López M; Colmenero A; Estévez M; Montalbán C; Martínez Á; Roncador G; García JF
Blood Adv; 2023 Aug; 7(15):4135-4147. PubMed ID: 36459489
[TBL] [Abstract][Full Text] [Related]
70. The biological environment of Hodgkin's lymphoma and the role of the chemokine CCL17/TARC.
Hnátková M; Mociková H; Trnený M; Zivný J
Prague Med Rep; 2009; 110(1):35-41. PubMed ID: 19591376
[TBL] [Abstract][Full Text] [Related]
71. Targetable molecular pathways in classical Hodgkin's lymphoma.
Adams H; Obermann EC; Dirnhofer S; Tzankov A
Expert Opin Investig Drugs; 2011 Feb; 20(2):141-51. PubMed ID: 21204722
[TBL] [Abstract][Full Text] [Related]
72. From Hodgkin disease to Hodgkin lymphoma: biologic insights and therapeutic potential.
Re D; Thomas RK; Behringer K; Diehl V
Blood; 2005 Jun; 105(12):4553-60. PubMed ID: 15728122
[TBL] [Abstract][Full Text] [Related]
73. Hodgkin lymphoma with cutaneous involvement.
Hsia CC; Howson-Jan K; Rizkalla KS
Dermatol Online J; 2009 May; 15(5):5. PubMed ID: 19624983
[TBL] [Abstract][Full Text] [Related]
74. U-HO1, a new cell line derived from a primary refractory classical Hodgkin lymphoma.
Mader A; Bruderlein S; Wegener S; Melzner I; Popov S; Muller-Hermelink HK; Barth TF; Viardot A; Moller P
Cytogenet Genome Res; 2007; 119(3-4):204-10. PubMed ID: 18253030
[TBL] [Abstract][Full Text] [Related]
75. Hodgkin lymphoma cell lines: to separate the wheat from the chaff.
Drexler HG; Pommerenke C; Eberth S; Nagel S
Biol Chem; 2018 May; 399(6):511-523. PubMed ID: 29533902
[TBL] [Abstract][Full Text] [Related]
76. Flow cytometry can diagnose classical hodgkin lymphoma in lymph nodes with high sensitivity and specificity.
Fromm JR; Thomas A; Wood BL
Am J Clin Pathol; 2009 Mar; 131(3):322-32. PubMed ID: 19228638
[TBL] [Abstract][Full Text] [Related]
77. Circulating clonotypic B cells in classic Hodgkin lymphoma.
Jones RJ; Gocke CD; Kasamon YL; Miller CB; Perkins B; Barber JP; Vala MS; Gerber JM; Gellert LL; Siedner M; Lemas MV; Brennan S; Ambinder RF; Matsui W
Blood; 2009 Jun; 113(23):5920-6. PubMed ID: 19188663
[TBL] [Abstract][Full Text] [Related]
78. [Picture in clinical hematology no. 39: composite hodgkin lymphoma and mantle cell lymphoma].
Senhara T; Aosasa K; Shibano S; Tsukaguchi M
Rinsho Ketsueki; 2009 Jul; 50(7):517. PubMed ID: 19638717
[No Abstract] [Full Text] [Related]
79. Mapping of transcription factor motifs in active chromatin identifies IRF5 as key regulator in classical Hodgkin lymphoma.
Kreher S; Bouhlel MA; Cauchy P; Lamprecht B; Li S; Grau M; Hummel F; Köchert K; Anagnostopoulos I; Jöhrens K; Hummel M; Hiscott J; Wenzel SS; Lenz P; Schneider M; Küppers R; Scheidereit C; Giefing M; Siebert R; Rajewsky K; Lenz G; Cockerill PN; Janz M; Dörken B; Bonifer C; Mathas S
Proc Natl Acad Sci U S A; 2014 Oct; 111(42):E4513-22. PubMed ID: 25288773
[TBL] [Abstract][Full Text] [Related]
80. Genomic Landscape of Hodgkin Lymphoma.
Brune MM; Juskevicius D; Haslbauer J; Dirnhofer S; Tzankov A
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33567641
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
